At the expo site, we are looking forward to the "China debut" of innovative drugs. A batch of new medical devices are breaking the original bottleneck and filling the gap, so that patients can enjoy higher quality medical services.
Baxter Medical brought China's first "China debut" of Icao dextrin peritoneal dialysis solution (Athojia), breaking a 30-year lack of new peritoneal dialysis solutions in China.
In China, more than 10 percent of the population suffers from chronic kidney disease, and patients who develop end-stage renal disease (ESRD) mainly rely on renal replacement therapy to survive. Peritoneal dialysis (PD) or hemodialysis (HD) is the primary renal replacement therapy for most patients with ESRD.
From the site of the CiIE, Bubuli learned that Avx is the world's leading innovative drug, which can achieve longer abdominal retention and does not contain glucose. Therefore, compared with traditional peritoneal dialysis solution, it has multiple clinical advantages, especially for patients with poor ultrafiltration and diabetes.
Experts believe that in the current situation of normalized epidemic prevention and control, peritoneal dialysis reduces the number of hospital visits, round-trip costs and time for patients, and is conducive to improving patients' treatment experience and efficiency.
Abbott's whole family of instant Digital intelligent solutions and its latest digital product LibrelinkUp APP also made their debut in China.
As a global leader in diabetes management, Abbott helps more people with diabetes manage their blood sugar scientifically through continuous technological innovation. The first product in China, Instant, can realize multi-party data sharing through cloud interconnection to achieve remote monitoring of blood glucose, forming a multi-directional intelligent blood glucose management system from home to Internet medical treatment.
"We hope to leverage the strong spillover effect of the CiEE to maximize access to cutting-edge technologies and medical services and further improve the diabetes management ecosystem," said Guo Jing, general manager of Abbott Diabetes in Mainland China and Hong Kong.
Termao has participated in the CiIE for four consecutive years, and 80% of its products are the first show products of the CIIE. Among them, the self-expandable WEBTM aneurysm embolization system developed by Telmao for aneurysm treatment made its debut at ciIE. It is the world's leading novel intratumoral turbulence device, which enables the safe and effective treatment of wide-necked bifurcated aneurysms with a single device. The product is released intravascular intervention to perform three-dimensional tamping of the aneurysm.
At this CIIE, stryker 1688 image platform was officially released, which will be launched in hospitals all over the country while completing its "debut" in China, benefiting patients.
With the development of modern medical science and technology, minimally invasive technology plays an important role in surgery. As an important helper of minimally invasive surgery, endoscope is like the doctor's "eye", which can help doctors better observe the patient's internal conditions. Traditional endoscopes usually only use white light imaging, but traditional high-definition endoscopes also have problems such as low resolution and color distortion.
As stryker's latest 4K endoscope system, the 1688 Imaging platform combines ultra-high definition 4K imaging and dual fluorescence navigation technology to help clinicians break through the limitations of traditional endoscopes.
In the past, the operation of traditional joint replacement surgery often needs to be decided according to the doctor's experience and estimation, and the surgical effect is very dependent on the operator's personal clinical experience and technology.
At the ciIE site, Stryker showed a Mako intelligent joint robot , which can accurately control the osteotomy operation within millimeters with the help of its flexible mechanical arm and only need to operate relevant machines.
The robot can also make personalized surgery plans for patients in advance, so that doctors can "see" the procedure in advance, He said.
With the continuous improvement of Chinese people's demand for health care, China's medical market has bred huge business opportunities. Bringing technologically advanced original medicines and innovative medical devices to the Chinese market can also meet the vast unmet clinical needs of patients in China. Held for four consecutive years, ciIE has become an important venue for multinational pharmaceutical companies and medical device giants to showcase their global R&D capabilities.
About Manly Battery
Located in Shenzhen,China. A leading battery manufacturer mainly offering rechargeable Lithium batteries over 12 years ,widly used for Robostic ,if there is any project need to evluate ,pls feel free to send email to info@manlybatteries.com
